Agrobacterium-mediated transformation of lettuce (Lactuca sativa l.) to express IgG-binding protein a and human pro-insulin as a fusion protein

Journal of Horticultural Science and Biotechnology

Volumn 89, Issue 6, 2014, Pages 719-725

  Mohebodini, M ^a,d   Jalali Javaran, M J ^a   Alizadeh, H ^b   Mahboudi, F ^c   Yarbakht, M ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d UNIVERSITY OF MOHAGHEGH ARDABILI   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AGROBACTERIUM; LACTUCA; LACTUCA SATIVA;

EID: 84908700864     PISSN: 14620316     EISSN: None     Source Type: Journal    
DOI: 10.1080/14620316.2014.11513143     Document Type: Article

References (40)

1. ARAKAWA, T., YU, J., CHONG, D. K., HOUGH, J., ENGEN, P. C. and LANGRIDGE, W. H. (1998). A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nature Biotechnology, 16, 934-938.
2. st century and the role of plants and plant cells as production platforms. Annals of the New York Academy of Sciences, 1102, 121-134.
3. BOYHAN, D. and DANIELL, H. (2011). Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnology Journal, 9, 585-598.
4. BOOTHE, J., NYKIFORUK, C., SHEN, Y., ZAPLACHINSKI, S., SZARKA, S., KUHLMAN, P., MURRAY, E., MORCK, D. and MOLONEY, M. M. (2010). Seed-based expression systems for plant molecular farming. Plant Biotechnology Journal, 8, 588-606.
5. BRADFORD, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
6. CARTER III, J. E. and LANGRIDGE, W. H. R. (2002). Plant-based vaccines for protection against infectious and autoimmune diseases. Critical Reviews in Plant Sciences, 21, 93-109.
7. CHEN, H., NELSON, R. S. and SHERWOOD, J. L. (1994). Enhanced recovery of transformants of Agrobacterium tumefaciens after freeze-thaw transformation and drug selection. Biotechniques, 16, 664-670.
8. DING, Y L., Aldao-Humble, G., LUDLOW, E., DRAYTON, M., LIN, Y H., NAGEL, J., DUPAL, M., ZHAO, G., PALLAGHY, C., KALLA, R., EMMERLING, M. and SPANGENBERG, G. (2003). Efficient plant regeneration and Agrobacterium-mediated transformation in Medicago and Trifolium species. Plant Science, 165, 1419-1427.
9. FLOSS, D. M., FALKENBURG, D. and CONRAD, U. (2007). Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: An overview. Transgenic Research, 16, 315-332.
10. GIDDINGS, G., ALLISON, G., BROOKS, D. and CARTER, A. (2000). Transgenic plants as factories for biopharmaceuticals. Nature Biotechnology, 18, 1151-1155.
11. HELLWIG, S., DROSSARD, J., TWYMAN, R. M. and FISCHER, R. (2004). Plant cell culture for the production of recombinant proteins. Nature Biotechnology, 22, 1415-1422.
12. JOHANSSON, B. L., SJOBERG, S. and WAHREN, J. (1992). The influence of human C peptide on renal function and glucose utilization in the type I (insulin-dependent) diabetic patients. Diabetologia, 35, 121-128.
13. JOHANSSON, B. L., KERNELL, A., SJOBERG, S. and WAHREN, J. (1993). Influence of combined C peptide and insulin administration on renal function and metabolic control in diabetes Type I. Journal of Clinical Endocrinology & Metabolism, 77, 976-981.
14. KAPUSTA, J., MODELSKA, A., FIGLEROWICZ, M., PNIEWSKI, T., Letel-Lier, M., LISOWA, O., YUSIBOV, V., KOPROWSKI, H., Plucien-Niczak, A. and LEGOCKI, A. B. (1999). A plant-derived edible vaccine against hepatitis B virus. FASEB Journal, 13, 1796-1799.
15. KOYA, V., MOAYERI, M., LEPPLA, S. H. and DANIELL, H. (2005). Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infection and Immunity, 73, 8266-8274.
16. LA, P., RAMACHANDRAN, V. G., GOYAL, R. and SHARMA, R. (2007). Edible vaccines: current status and future. Indian Journal of Medical Microbiology, 25, 93-102.
17. LAEMMLI, U. K. (1970). Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature, 227, 680-685.
18. LEROUGE, P., Cabanes-Macheteau, M., RAYON, C., Fischette-Lainé, A. C., GOMORD, V. and FAYE, L. (1998). N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Molecular Biology, 38, 31-48.
19. LI, D., O’leary, Y., HUANG, N., HUNER, P. A., JEVNIKAR, A. M. and MA, S. (2006). Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants. Plant Cell Reports, 25, 417-424.
20. LIU, Y. G., MITSUKAWA, N. and OOSUMI, T. (1995). Efficient isolation and mapping of Arabidopsis thaliana T-DNA insert junctions by thermal asymmetric interlaced PCR. Plant Journal, 8, 457-463.
21. MA, J. K., CHIKWAMBA, R., SPARROW, P., FISCHER, R., MAHONEY, R. and TWYMAN, R. M. (2005). Plant-derived pharmaceuticals the road forward. Trends in Plant Science, 10, 580-585.
22. Marquet-Blouin, E., BOUCHE, F. B., STEINMETZ, A. and MULLER, C. P. (2003). Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin. Plant Molecular Biology, 51, 459-469.
23. MASON, H. S., BALL, J. M., SHI, J. J., JIANG, X., ESTES, M. K. and ARNTZEN, C. J. (1996). Expression of Norwalk virus capsid protein in transgenic tobacco and protein and its oral immunogenicity in mice. Proceedings of the National Academy of Sciences of the USA, 93, 5335-5340.
24. MCGARVEY, P. B., HAMMOND, J., DIENELT, M. M., HOOPER, D. C., FU, Z. F., DIETZSCHOLD, B., KOPROWSK, H. and MICHAELS, F. H. (1995). Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology, 13, 1484-1487.
25. MOHEBODINI, M., Jalali-Javaran, M., MAHBOUDI, F. and ALIZADEH, H. (2011). Effects of genotype, explant age and growth regulators on callus induction and direct shoot regeneration of lettuce (Lactuca sativa L.). Australian Journal of Crop Science, 5, 92-95.
26. MURASHIGE, T. and SKOOG, F. (1962). A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiologia Plantarum, 15, 473-497.
27. NAGATA, M., SANTAMARIA, P., KAWAMURA, T., UTSUGI, T. and YOON, J. W. (1994). Evidence for the role of CD8 cytotoxic T cells in the destruction of pancreatic -cells in non-obese diabetic mice. Journal of Immunology, 152, 2042-2050.
28. PLOIX, C., BERGEROT, I., DURAND, A., CZERKINSKY, C., HOLMGREN, J. and THIVOLET, C. (1999). Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4 regulatory T-cells. Diabetes, 48, 2150-2156.
29. RAAB, R., FEZEU, L. and MBANYA, J. C. (2004). Cost and availability of insulin and other diabetes supplies: IDF survey 2002-2003. Diabetes Voice, 49, 24-29.
30. Rosales-Mendoza, S., Soria-Guerra, R. E., Olivera-Flores, M. J., López-Revilla, R., Argüello-Astorga, G., Jiménez-Bremont, J. F., GARCÍADE LA CRUZ, R. F., Loyola-Rodríguez, J. P. and Alpuche-Solís, A. G. (2007). Expression of Escherichia coli heat-labile enterotoxin b subunit (LTB) in carrot (Daucus carota L.). Plant Cell Reports, 26, 969-976.
31. RUHLMAN, T., AHANGARI, R., DEVINE, A., SAMSAM M. and DANIELL, H. (2007). Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnology Journal, 5, 495-510.
32. RYBICKI, E. P. (2010). Plant-made vaccines for humans and animals. Plant Biotechnology Journal, 8, 620-637.
33. SAMBROOK, J., FRITSCH, E. F. and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY, USA. 1659 pp.
34. SANDHU, J. S., KRASNYANSKI, S. F., DOMIER, L., KORBAN, S. S., OSADJAN, M. D. and BUETOW, D. E. (2000). Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Research, 9, 127-135.
35. SAS INSTITUTE (2003). SAS/STAT User Guide (Version 9.1). SAS Institute Inc., Cary, NC, USA.
36. SHAW, J. A. M., DELDAY, M., HART, A. W., DOCHERTY, H. M., MALTIN, C. A. and DOCHERTY, K. (2002). Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. Journal of Endocrinology, 172, 653-672.
37. STAUB, J. M., GARCIA, B., GRAVES, J., HAJDUKIEWICZ, P. T., HUNTER, P., NEHRA, N., PARADKAR, V., SCHLITTLER, M., CARROLL, J. A., SPATOLA, L., WARD, D., YE, G. and RUSSELL, D. A. (2000). Highyield production of a human therapeutic protein in tobacco chloroplasts. Nature Biotechnology, 18, 333-338.
38. STEINER, D. F. (1998). The proprotein convertases. Current Opinion in Chemical Biology, 2, 31-39.
39. WEBSTER, D. E., SMITH, S. D., PICKERING, R. J., STRUGNELL, R. A., DRY, I. B. and WESSELINGH, S. L. (2006). Measles virus hemaglutinin protein expressed in transgenic lettuce induces neutralizing antibodies in mice following mucosal vaccination. Vaccine, 24, 3538-3544.
40. YUSIBOV, V. and RABINDRAN, S. H. (2004). Plant viral expression vectors: history and new developments. In: Molecular Farming: Plant-Made Pharmaceuticals and Technical Proteins. (Fischer, R. and Schillberg, S., Eds.). Wiley VCH, Weinheim, Germany. 77-90.